Soligenix(SNGX)
PRINCETON, NJBiotechnology
Focus: Soligenix is a public biotech company focused on lipoprotein delivery and small molecule therapeutics across oncology, gastroenterology, and immunology. The company is in early-stage clinical development with minimal commercial revenue.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Soligenix
AI assessmentNot HiringNo open roles listed right now. Follow Soligenix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$119K
Pipeline & Clinical Trials
SGX201
EnteritisClinical Trials (1)
NCT01073384A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
Phase 1/2Help build intelligence for Soligenix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.